StockData
Amylyx Pharmaceuticals, Inc. logo

Amylyx Pharmaceuticals, Inc. (AMLX) stock

AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$27.52−0.28 (-1.01%)

Close on Nov 17, 2026Market cap $3.07BP/E –Yield –

Amylyx Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Amylyx Pharmaceuticals's market cap was $3.54B on Nov 11, 2026, against $1.64B a year earlier. Over the last 5 years it ranged from $63.18M to $3.76B, with a median of $1.24B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.54B+167.1%
2025Dec 31, 2025$1.33B+411.8%
2024Dec 31, 2024$259.10M-73.9%
2023Dec 29, 2023$993.68M-54.1%
2022Dec 30, 2022$2.16B–

More Amylyx Pharmaceuticals figures

See a number that looks wrong?